Data Foundry

Drug recalls 2014

SERTRALINE HCL Tablet — Class II drug recall D-523-2014

Terminated recall by Aidapak Services, LLC, reported 2014-01-22, distributed in AZ, CA, OR, WA. Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsul

Recall numberD-523-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAidapak Services, LLC, Vancouver, WA, United States
Recall initiated2013-07-02
Classified2014-01-16
Reported by FDA2014-01-22
Terminated2014-02-07
DistributedAZ, CA, OR, WA
Quantity500 tablets
Reason classeslabeling
Expiration dates2014-05-09, 2014-05-15, 2014-05-29, 2014-06-12, 2014-06-24

Product

SERTRALINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714061204

Reason for recall

Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 10 mg, NDC 00093081001, Pedigree: AD70585_4, EXP: 5/29/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003574, EXP: 6/24/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD46300_17, EXP: 5/15/2014; CHOLECALCIFEROL, Tablet,

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-523-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.